Victor Lam

heart failure pharmacist 🫀💊

[Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 @DrMarthaGulati]

#ESCCongress Hotline #DICTATEAHF
🎯early initiation of dapagliflozin in AHF🏥 RCT Dapa (w/in 24h) vs UC acute tx-39% 💃🏻
🎯 Dapa provided improved diuresis and ⤵️ diuretics + ⤵️🏥 stay
🎯 Supports start GDMT fast & Dapa early even if they didn’t meet 1o endpoint

[Gregg Fonarow MD @gcfmd]

🏨 HFrEF

Early in-🏨 initiation effects on early clinical outcomes:

ARNI ➡️ -42% risk CV☠️/HF🏨
BB ➡️ -25% risk ☠️
MRA ➡️ -37% risk CV☠️/HF🏨
SGLTi ➡️ -58% risk CV☠️/HF🏨 or ER/UC visit

Unnecessary delays in GDMT ➡️ clinical events which could have been prevented

@JAMACardio

[ACCP Cardiology PRN @accpcardprn]

💊TBT💊 EMPULSE Trial revealed empagliflozin is SAFE and EFFECTIVE for ADHF in hemodynamically stable hospitalized patients. Another reason to start GDMT ASAP! Check out the infographic made by current PGY2 🫀 Resident @juliarobynjames! #CardioTwitter https://t.co/CKVvDf7lo1

[Alfonso Valle @ValleAlfonso]

SGLT2i therapy for transthyretin amyloid cardiomyopathy: early tolerance and clinical response to dapagliflozin
👉 tafamidis-treated ATTR-CM👥, initiation of dapagliflozin was well tolerated
👉💊DAPA ⤵️NT-proBNP; ⤵️diuretics demand
📁 https://t.co/viTFQPf0mq

[ACCP Cardiology PRN @accpcardprn]

It's #TeachingTuesday and @ADan_osine created a phenomenal infographic about 🧂 hypertonic saline's 🧂 use in diuretic resistance! Have you utilized this approach to combat hypochloremia in ADHF? 🫀

[ACCP Cardiology PRN @accpcardprn]

⚙️ Mechanical Circulatory Support ⚙️ taught by the wonderful @ami__odarone ! Do you know the differences between the IABP, Impella, and VA-ECMO?

[CSHP OB @CSHP_OB]

⭐ In today's #PAM2023 Pharmacy Professional Highlight, we hear from Mira Maximos from Metro Toronto Chapter on her journey and endeavours in the pharmacy profession, and why she is proud of being a pharmacist. #ThankYouPharmacy

See full highlight here: https://t.co/lfW1CNe4wA

[CSHP OB @CSHP_OB]

This #PAM2023, CSHP OB will highlight the hard work, dedication, and accomplishments of our pharmacy professionals in Ontario. Today we share the experiences of Victor Lam on being a Heart Function Clinic pharmacist. #ThankYouPharmacy

Full highlight here: https://t.co/vfE4SMAnCr

[ACCP Cardiology PRN @accpcardprn]

Happy #TeachingTuesday! This week courtesy of @HannahDykesRX we have an overview of the STRONG-HF 💪 trial. See below for results of rapid titration of HF GDMT compared to usual care regardless of EF in a post-discharge population! How will these results affect practice?

[EHJ Editor-in-Chief @ehj_ed]

Genetic causes of heart failure with preserved ejection fraction: emerging pharmacological treatments. Read more in EHJ!
https://t.co/jf7V8uTS9V
#HFpEF #Hypertrophic #Fabry #Amyloidosis #Drug #cardiotwitter @ESC_Journals @escardio

[Henry Han @HanCardiomd]

This review provides a comprehensive overview of drug and device management approaches for patients with HFrEF, and #GDMT in the management of patients with #HFrEF

@JavedButler1 @SJGreene_md @ShahzebKhanMD @FudimMarat

#CardioEd #HeartFailure
https://t.co/0NbIpHUfFz

[Henry Han @HanCardiomd]

The year in cardiovascular medicine 2022: the top 10 papers in #HeartFailure and #Cardiomyopathies

The year of 2022 has been an exciting year in heart failure (HF)

https://t.co/QhMLqYXMgs

#CardioTwitter @rudolf_deboer @ESC_Journals

[Jonathan Davis, MD, MPHS @JonathanDavisHF]

During this holiday season, many folks w #HeartFailure will present volume⬆️. For those orthostatic, Rx is🚫loop diuretic &⬆️fluid intake. Rx is NOT to stop ARNI/BB/MRA/SGLT2i. @UCSFIMChiefs @ucsfdgimzsfg @AndrewJSauer @SantosGallegoMD @rachkataria @gcfmd @SJGreene_md @AHajduczok

[CSHP OB @CSHP_OB]

CSHP Ontario Branch is now on LinkedIn! 🎊

Follow our LinkedIn page to learn about our work on advancing pharmacy practice in Ontario's hospitals and collaborative healthcare settings, and how you can be a part.

Link: https://t.co/cQSuGsJVh2

[Enrique Garcia-Sayan, MD, FACC, FASE @EGarciaSayan]

8/ How do we manage LVOTo?
🔺🚫vasodilators and aggressive diuresis
🔺Beta blockers +/- verapamil or diltiazem
🔺Refractory Sx + gradient ≥ 50 mmHg: add disopyramide, refer for septal reduction therapy (SRT)
🔺VALOR-HCM trial: mavacamten reduced eligibility for needing SRT

[ACCP Cardiology PRN @accpcardprn]

Welcome back to #TeachingTuesday! Today we are reviewing SGLT2 inhibitors in acute decompensated heart failure, thanks to @danielnguyendo (and mentor @Chelsea_barvian)! How is your hospital working to capitalize on opportunities to improve GDMT initiation and adherence?

[🥕Devesh Rai, MD🥕 @DeveshRaiMD]

Role of statins in patients with NAFLD

✅Statins are vastly underutilized in patients with NAFLD
✅Hepatic steatosis increase the risk of CAD
✅Multiple shared risk factors between obesity, DM and NAFLD

#ASPC2022
@kcferdmd @DrMarthaGulati @CardioNerds

[Jonathan Davis, MD, MPHS @JonathanDavisHF]

Neither MRA nor SGLT2i will meaningfully impact BP in HF patients. They are not they reason your pt is hypotensive & can be safely started/used even at lower BP. Start #GDMTWorks & save lives! @gcfmd @AndrewJSauer @mvaduganathan @DrNasrien @dranulala @SJGreene_md @UCSFIMChiefs

[Mohamad Soud @mhd_soud]

A quick summary of the trials & studies presented at #ACC22 @ACCinTouch @NJACC

[American College of Cardiology @ACCinTouch]

Check out the 10 🗝️ points to remember from the @ehj_ed state-of-the-art review on electrical management of #HeartFailure: https://t.co/LiXiZx59Ys

#cvHCM #AFib #EPeeps #CardioTwitter